Log In
Print
BCIQ
Print
Print this Print this
 

Evoclin, clindamycin

Also known as: formerly Actiza, Actiza 1% foam

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionFoam formulation of 1% clindamycin
Molecular Target Ribosomal 50S subunit
Mechanism of ActionProkaryotic protein synthesis inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAcne
Indication DetailsTreat acne vulgaris
Regulatory Designation

Partner

Renaissance Acquisition Holdings LLC


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today